Acitrin-L 2.5 mg/5 ml (Oral Solution)

Indications

• Perennial allergic rhinitis
• Seasonal allergic rhinitis
• Chronic idiopathic urticaria

Pharmacology

• Contains Levocetirizine Dihydrochloride
• Highly effective nonsedating antihistamine
• Potent antiallergic properties
• Two-fold higher affinity for H1 receptors than cetirizine
• Rapid and long-acting action
• Once-a-day administration

Dosage & Administration

• Recommended dose for adults and children 12 years and older: 5 mg once daily
• Recommended dose for children 6 to 11 years of age: 2.5 mg once daily
• Recommended dose for children 6 months to 5 years of age: 1.25 mg once daily
• Pediatric use based on efficacy extrapolation from adults
• No sufficient data for geriatric use
• No dosage adjustment in hepatic impairment
• Different dosages for mild, moderate, and severe renal impairment
• Patients with end-stage renal disease or undergoing hemodialysis should not receive Levocetirizine

Interaction

Not known to have any interactions with other drugs

Contraindications

• Hypersensitivity to levocetirizine, cetirizine, or hydroxyzine
• Severe renal impairment (creatinine clearance: <10 ml/min)

Side Effects

• Well tolerated, but rare reports of headache, dry mouth, fatigue, and skin rash

Pregnancy & Lactation

• Pregnancy Category B
• Use during pregnancy only if clearly needed
• Not recommended for nursing mothers

Precautions & Warnings

• Epileptic patients and patients at risk of convulsions
• Renal impairment
• Pregnancy and lactation

Overdose Effects

No clinically relevant adverse events reported, symptomatic and supportive treatment recommended in case of overdose

Therapeutic Class

Non-sedating antihistamines

Storage Conditions

Store at a temperature not exceeding 30°C in a dry place, protect from light

Related Brands

• Acitrin-L 5 mg (Tablet) - aci-limited